iron sucrose


Great Eastern Drug


Zuellig Pharma
Concise Prescribing Info
Fe sucrose complex
Fe deficiency anemia for non-dialysis dependent-chronic kidney disease (NDD-CKD) patients receiving & not receiving an erythropoietin, hemodialysis dependent-chronic kidney disease (HDD-CKD) patients receiving erythropoietin, peritoneal dialysis dependent-chronic kidney disease (PDD-CKD) patients receiving an erythropoietin.
Dosage/Direction for Use
HDD-CKD Administer undiluted as 100 mg slow IV inj over 2-5 min or 100 mg as infusion, diluted in a max of 100 mL of 0.9% NaCl over a period of at least 15 min per consecutive hemodialysis session for a total cumulative dose of 1,000 mg. NDD-CKD Administer as a total cumulative dose of 1,000 mg over a 14-day period as a 200 mg slow IV inj undiluted over 2-5 min on 5 different occasions w/in the 14 days period. PDD-CKD Administer as a total cumulative dose of 1,000 mg in 3 divided doses, given by slow IV infusion & should be diluted in max of 250 mL of 0.9% NaCl.
Hypersensitivity. Patients w/ evidence of Fe overload & those w/ anemia not caused by Fe deficiency.
Special Precautions
Periodic monitoring of hematologic & hematinic parameters (Hb, hematocrit, serum ferritin & transferring saturation). Withhold in patients w/ evidence of Fe overload. Pregnancy & lactation.
Adverse Reactions
Hypotension, muscle cramps, nausea, headache, graft complications, vomiting, dizziness, HTN, chest pain, diarrhea; peritoneal infection, pharyngitis, peripheral edema, nausea; dysgeusia, peritoneal edema, diarrhea, constipation, HTN dyspnea; arthralgia, back pain, extremely pain & inj site burning.
Drug Interactions
May reduce the absorption of oral Fe prep.
ATC Classification
B03AC - Iron, parenteral preparations ; Used in the treatment of anemia
Ferogen inj 20 mg/mL
5 mL x 5 × 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in